The Claim
In adults aged 60–65 without cardiovascular disease but at intermediate risk, daily combination therapy with rosuvastatin (10 mg), candesartan (16 mg), and hydrochlorothiazide (12.5 mg) for a median of 5.6 years reduces the risk of major cardiovascular events—death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke—by 29% compared to dual placebo, with an absolute risk reduction of 1.4 percentage points and a number needed to treat of 72.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In adults aged 60–65 at intermediate risk for cardiovascular disease but without existing cardiovascular disease, taking a daily pill containing rosuvastatin, candesartan, and hydrochlorothiazide for about 5.6 years reduces the rate of heart attacks, strokes, or cardiovascular death by 29% compared to taking two placebo pills.
See the scientific wording
In adults aged 60–65 without cardiovascular disease but at intermediate risk, daily combination therapy with rosuvastatin (10 mg), candesartan (16 mg), and hydrochlorothiazide (12.5 mg) for a median of 5.6 years reduces the risk of major cardiovascular events—death from cardiovascular causes, nonfatal myocardial infarction, or nonfatal stroke—by 29% compared to dual placebo, with an absolute risk reduction of 1.4 percentage points and a number needed to treat of 72.
Lowering bad cholesterol prevents fatty buildup in artery walls, while lowering blood pressure reduces force on those walls; together, this stops plaques from rupturing and blocks blood clots that cause heart attacks and strokes.
What the research says
1 studyStudy: Blood-Pressure and Cholesterol Lowering in Persons without Cardiovascular Disease.
For older adults at moderate risk of heart problems but without prior heart disease, taking one pill with three medicines every day for about six years lowered their chance of having a heart attack, stroke, or dying from heart disease by 1.4 percentage points — meaning about 1 in 72 people avoided a major event.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.